These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38007382)

  • 21. Emerging trends in the diagnosis and treatment of acromegaly in Canada.
    Vallette S; Ezzat S; Chik C; Ur E; Imran SA; Van Uum S; Rivera J; Caspar-Bell G; Serri O
    Clin Endocrinol (Oxf); 2013 Jul; 79(1):79-85. PubMed ID: 23190441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acromegaly and male sexual health.
    Salvio G; Martino M; Balercia G; Arnaldi G
    Rev Endocr Metab Disord; 2022 Jun; 23(3):671-678. PubMed ID: 35364803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics and treatment outcomes of micromegaly - acromegaly with apparently normal basal GH: A retrospective study and literature review.
    Inacio I; Fonseca L; Amado A; Benido V; Ribeiro I; Dores J; Amaral C; Cardoso MH
    Endocr Regul; 2022 Apr; 56(2):87-94. PubMed ID: 35489048
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical features and therapeutic outcomes of 65 patients with acromegaly at Tokyo Women's Medical University.
    Fukuda I; Hizuka N; Murakami Y; Itoh E; Yasumoto K; Sata A; Takano K
    Intern Med; 2001 Oct; 40(10):987-92. PubMed ID: 11688841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of neoplasms in patients with acromegaly - the need for a national registry.
    Matyjaszek-Matuszek B; Obel E; Lewicki M; Kowalczyk-Bołtuć J; Smoleń A
    Ann Agric Environ Med; 2018 Sep; 25(3):559-561. PubMed ID: 30260174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Acromegaly and it's cardiovascular implications].
    Cadena-Obando DA; Remba-Shapiro I; Abreu-Rosario CG; Mercado M
    Rev Med Inst Mex Seguro Soc; 2021 Feb; 59(1):73-80. PubMed ID: 33667046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complications and Comorbidities of Acromegaly-Retrospective Study in Polish Center.
    Rolla M; Jawiarczyk-Przybyłowska A; Halupczok-Żyła J; Kałużny M; Konopka BM; Błoniecka I; Zieliński G; Bolanowski M
    Front Endocrinol (Lausanne); 2021; 12():642131. PubMed ID: 33796075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acromegaly in the elderly patients.
    Ambrosio MR; Gagliardi I; Chiloiro S; Ferreira AG; Bondanelli M; Giampietro A; Bianchi A; Marinis L; Fleseriu M; Zatelli MC
    Endocrine; 2020 Apr; 68(1):16-31. PubMed ID: 32060689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Liege Acromegaly Survey (LAS): a new software tool for the study of acromegaly.
    Petrossians P; Tichomirowa MA; Stevenaert A; Martin D; Daly AF; Beckers A
    Ann Endocrinol (Paris); 2012 Jun; 73(3):190-201. PubMed ID: 22682917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. THE PREVALENCE OF CANCER AND ITS RELATION TO DISEASE ACTIVITY IN PATIENTS WITH ACROMEGALY: TWO CENTERS' EXPERIENCE.
    Ucan B; Kizilgul M; Karci AC; Duger H; Erkam Sencar M; Imga NN; Demirci T; Berker D; Erman Cakal
    Endocr Pract; 2021 Jan; 27(1):51-55. PubMed ID: 33475501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic complications of acromegaly: epidemiology, pathogenesis, and management.
    Colao A; Ferone D; Marzullo P; Lombardi G
    Endocr Rev; 2004 Feb; 25(1):102-52. PubMed ID: 14769829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acromegaly pathogenesis and treatment.
    Melmed S
    J Clin Invest; 2009 Nov; 119(11):3189-202. PubMed ID: 19884662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer in growth hormone excess and growth hormone deficit.
    Guevara-Aguirre J; Peña G; Acosta W; Pazmiño G; Saavedra J; Soto L; Lescano D; Guevara A; Gavilanes AWD
    Endocr Relat Cancer; 2023 Oct; 30(10):. PubMed ID: 37428642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The changing face of acromegaly--advances in diagnosis and treatment.
    Ribeiro-Oliveira A; Barkan A
    Nat Rev Endocrinol; 2012 Oct; 8(10):605-11. PubMed ID: 22733271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of acromegaly on thyroid disease.
    Mo C; Zhong L
    Endocr J; 2023 Nov; 70(11):1051-1060. PubMed ID: 37880078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discordant GH and IGF-1 Results in Treated Acromegaly: Impact of GH Cutoffs and Mean Values Assessment.
    Campana C; Cocchiara F; Corica G; Nista F; Arvigo M; Amarù J; Rossi DC; Zona G; Ferone D; Gatto F
    J Clin Endocrinol Metab; 2021 Mar; 106(3):789-801. PubMed ID: 33236108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamic tests and basal values for defining active acromegaly.
    Tzanela M
    Neuroendocrinology; 2006; 83(3-4):200-4. PubMed ID: 17047383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Could different treatment approaches in acromegaly influence life expectancy? A comparative study between Bulgaria and Campania (Italy).
    Colao A; Vandeva S; Pivonello R; Grasso LF; Nachev E; Auriemma RS; Kalinov K; Zacharieva S
    Eur J Endocrinol; 2014 Aug; 171(2):263-73. PubMed ID: 24878680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prevalence of benign and malignant tumors in patients with acromegaly at a single institute.
    Kurimoto M; Fukuda I; Hizuka N; Takano K
    Endocr J; 2008 Mar; 55(1):67-71. PubMed ID: 18202526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of growth hormone (GH) and insulin-like growth factor I on prostate diseases: an ultrasonographic and endocrine study in acromegaly, GH deficiency, and healthy subjects.
    Colao A; Marzullo P; Spiezia S; Ferone D; Giaccio A; Cerbone G; Pivonello R; Di Somma C; Lombardi G
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1986-91. PubMed ID: 10372698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.